Philip Helliwell

30.1k citations
410 papers · 15.9k · 6 hit papers · h-index 59

Impact in

  • Rheumatology top 0.01%
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Hematology top 0.2%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Spondyloarthritis Studies and Treatments 264
    • Rheumatoid Arthritis Research and Therapies 133
    • Psoriasis: Treatment and Pathogenesis 122

Philip Helliwell

392 papers receiving 15.3k citations

Philip Helliwell's Hit Papers

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial 2020 · 240 citations
2400+6+13Years since publication50010001.5k2.0k2.5k

Peers

Philip Helliwell
Comparison fields: 5 of 153
  • Rheumatology 11.2k
  • Hematology 3.0k
  • Immunology 5.1k
  • Orthopedics and Sports Medicine 696
  • Dermatology 651
Replace Laure Gossec with:
Laure Gossec France
Walter P. Maksymowych Canada
Andrei Călin United Kingdom
Daniel Wendling France
Sjef van der Linden Netherlands
Atul Deodhar United States
Donald M. Mitchell United States
A. Zink Germany
Carlo Salvarani Italy
Mikkel Østergaard Denmark
Philip Helliwell relative to Laure Gossec France Laure Gossec's profile →
Citations per field
00.5×1.5×2.5×
Laure Gossec · 1×
Citations per year

Countries citing papers authored by Philip Helliwell

Since Specialization
Citations

This map shows the geographic impact of Philip Helliwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Helliwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Helliwell more than expected).

Fields of papers citing papers by Philip Helliwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Helliwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Helliwell. The network helps show where Philip Helliwell may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip Helliwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Helliwell Line = papers co-authored together Philip Helliwell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 410 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
Hit paper breakdown →
20062722
2
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment
Hit paper breakdown →
2009491
3 2002471
4
Treatment recommendations for psoriatic arthritis
Hit paper breakdown →
2008428
5 2008342
6
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
Hit paper breakdown →
2015338
7
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
Hit paper breakdown →
2020240
8 2017230
9 2008217
10
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
Hit paper breakdown →
2019216
11 2005215
12
Comparison of disability and quality of life in rheumatoid and psoriatic arthritis.
2001206
13
Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire.
2009198
14 2009185
15 2010175
16 2007163
17 2018162
18
A randomized controlled trial of foot orthoses in rheumatoid arthritis.
2002160
19 2010159
20 1998157

About Philip Helliwell

Philip Helliwell is a scholar working on Rheumatology, Immunology, Hematology, Orthopedics and Sports Medicine and Surgery, having authored 410 papers that have together received 15.9k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (264 papers), Rheumatoid Arthritis Research and Therapies (133 papers), Psoriasis: Treatment and Pathogenesis (122 papers), Autoimmune and Inflammatory Disorders Research (56 papers), Diabetic Foot Ulcer Assessment and Management (8 papers), Dermatology and Skin Diseases (8 papers), Foot and Ankle Surgery (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers). The work is most often cited by research in Rheumatology (11.2k citations), Hematology (3.0k citations), Immunology (5.1k citations), Orthopedics and Sports Medicine (696 citations) and Dermatology (651 citations). Philip Helliwell has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Laura C. Coates, Philip J. Mease, Dafna D. Gladman, William J. Taylor, Antonio Marchesoni, Herman Mielants, Paul Healy, James Woodburn, Robin Waxman and Paul Emery. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Lara D. Veeken, Clinical Rheumatology and Arthritis Care & Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact